Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,139,284
+$1,685,277 QoQ
Shares Held
114,707
+201.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. TRVI ranks #95 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in TRVI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,139,284 | 114,707 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $454,007 | 38,056 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,268,012 | 101,279 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $509,526 | 55,686 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $225,205 | 41,171 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $258,493 | 41,096 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $136,165 | 33,050 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $78,449 | 23,488 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $69,963 | 23,478 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $58,093 | 16,839 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $17,369 | 12,962 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $22,399 | 10,275 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $37,850 | 15,837 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $490 | 265 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $503 | 261 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $214 | 139 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $466 | 166 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $160 | 73 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $57 | 73 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $64 | 46 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $74 | 33 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $65 | 24 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $53 | 22 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $88 | 22 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $236 | 36 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $118 | 36 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||